Imbalances in circulating lymphocyte subsets in Hu antibody associated paraneoplastic neurological syndromes

被引:6
作者
de Beukelaar, J. W.
Smitt, P. A. Sillevis
Hop, W. C.
Kraan, J.
Hooijkaas, H.
Verjans, G. M. G. M.
Gratama, J. W.
机构
[1] Erasmus Univ, Ctr Med, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands
[2] Erasmus Univ, Ctr Med, Dept Neurol, NL-3075 EA Rotterdam, Netherlands
[3] Erasmus Univ, Ctr Med, Dept Epidemiol & Biostat, NL-3075 EA Rotterdam, Netherlands
[4] Erasmus Univ, Ctr Med, Dept Immunol, NL-3075 EA Rotterdam, Netherlands
[5] Erasmus Univ, Ctr Med, Dept Virol, NL-3075 EA Rotterdam, Netherlands
关键词
Hu antibodies; immune phenotype; paraneoplastic syndrome; small cell lung cancer; T lymphocytes;
D O I
10.1111/j.1468-1331.2007.01986.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In paraneoplastic neurological syndromes (PNS) associated with small cell lung cancer (SCLC) and Hu antibodies, neuron-specific Hu antigens expressed by the tumour hypothetically trigger an immune response that cross-reacts with Hu antigens in the nervous system, resulting in tumour suppression and neuronal damage. To gain more insight into the hypothesized cell-mediated immune pathogenesis of these syndromes, we analysed the circulating lymphocyte subsets in untreated patients with SCLC, PNS and Hu antibodies (n = 18), SCLC without PNS (n = 19) and controls (n = 29) using flow cytometry. SCLC patients with PNS had a variety of imbalances within their circulating lymphocyte subsets as compared with SCLC patients without PNS and healthy controls: (i) a lymphopenia of the major subsets (i.e. B, CD4(+) and CD8(+) T lymphocytes); (ii) increased proportions of activated CD4(+) and CD8(+) T cells; (iii) reduced numbers of terminally differentiated effector CD8(+) T cells and cells with a cytotoxic T-cell phenotype (CD56(+) and CD57(+)). Although indirect, our data provide further support for the involvement of T cells in the pathogenesis of Hu antibody associated PNS.
引用
收藏
页码:1383 / 1391
页数:9
相关论文
共 61 条
[1]  
Albert ML, 2000, ANN NEUROL, V47, P9
[2]   ABNORMALITIES OF LYMPHOCYTE SUBSETS IN POLYMYOSITIS [J].
BEHAN, WMH ;
BEHAN, PO ;
MICKLEM, HS ;
DURWARD, WF .
BRITISH MEDICAL JOURNAL, 1983, 287 (6386) :181-182
[3]   Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients [J].
Benveniste, O ;
Chérin, P ;
Maisonobe, T ;
Merat, R ;
Chosidow, O ;
Mouthon, L ;
Guillevin, L ;
Flahault, A ;
Burland, MC ;
Klatzmann, D ;
Herson, S ;
Boyer, O .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3521-3529
[4]  
Benyahia B, 1999, ANN NEUROL, V45, P162, DOI 10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO
[5]  
2-R
[6]   Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis [J].
Bernal, F ;
Graus, F ;
Pifarré, A ;
Saiz, A ;
Benyahia, B ;
Ribalta, T .
ACTA NEUROPATHOLOGICA, 2002, 103 (05) :509-515
[7]   Cytotoxic T lymphocytes and autoimmunity [J].
Blanco, P ;
Viallard, JF ;
Pellegrin, JL ;
Moreau, JF .
CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (06) :731-734
[8]   Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor γ chain signalling cytokines and type IIFN, and increases susceptibility to activation-induced apoptosis [J].
Borthwick, NJ ;
Lowdell, M ;
Salmon, M ;
Akbar, AN .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (07) :1005-1013
[9]   Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells [J].
Brenchley, JM ;
Karandikar, NJ ;
Betts, MR ;
Ambrozak, DR ;
Hill, BJ ;
Crotty, LE ;
Casazza, JP ;
Kuruppu, J ;
Migueles, SA ;
Connors, M ;
Roederer, M ;
Douek, DC ;
Koup, RA .
BLOOD, 2003, 101 (07) :2711-2720
[10]   Spontaneous neurological improvement in anti-Hu associated encephalomyelitis [J].
Byrne, T ;
Mason, WP ;
Posner, JB ;
Dalmau, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (03) :276-278